HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

AuthorsMartyn E Caplin, Marianne Pavel, Philippe Ruszniewski
JournalThe New England journal of medicine (N Engl J Med) Vol. 371 Issue 16 Pg. 1556-7 (10 16 2014) ISSN: 1533-4406 [Electronic] United States
PMID25317881 (Publication Type: Letter, Comment)
Chemical References
  • Antineoplastic Agents
  • Peptides, Cyclic
  • Somatostatin
Topics
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Gastrointestinal Neoplasms (drug therapy)
  • Humans
  • Male
  • Neuroendocrine Tumors (drug therapy)
  • Pancreatic Neoplasms (drug therapy)
  • Peptides, Cyclic (therapeutic use)
  • Somatostatin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: